Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 106

    USFDA completes inspection at Laurus Labs

    USFDA completes inspection at Laurus Labs' AP unit

    Medical Dialogues Bureau19 July 2019 10:02 AM IST
    Mumbai: Laurus labs recently announced that they have completed the US Food and Drug Administration (USFDA) inspection of Unit 4 at Visakhapatnam,...
    Sterling Biotech bank fraud case: ED records statements of actor Dino Morea, DJ Aqeel

    Sterling Biotech bank fraud case: ED records statements of actor Dino Morea, DJ Aqeel

    Medical Dialogues Bureau19 July 2019 9:02 AM IST
    New Delhi: The Enforcement Directorate has recorded the state ments of Bollywood actor Dino Morea and DJ Aqeel in connection with the Sterling Biotech...
    Wockhardt new antibiotics under development to have positive impact in future, says founder Khorakiwala

    Wockhardt new antibiotics under development to have positive impact in future, says founder Khorakiwala

    Medical Dialogues Bureau18 July 2019 3:13 PM IST
    In his address to shareholders in the Annual Report for 2018-19, Khorakiwala said Wockhardt has several new chemical entities (NCEs) which are being...
    Over 10 lakh tablets of habit forming painkiller Tramadol seized, Chemist held

    Over 10 lakh tablets of habit forming painkiller Tramadol seized, Chemist held

    Farhat Nasim18 July 2019 12:07 PM IST
    Mohali: In a major crackdown, the Punjab Police recently busted an illegal racket running from a chemist shop and seized more than 10 lakh Tramadol...
    Patients with NASH have been enrolled in 3 phase III trials of Saroglitazar, says Zydus Cadila

    Patients with NASH have been enrolled in 3 phase III trials of Saroglitazar, says Zydus Cadila

    Medical Dialogues Bureau18 July 2019 9:17 AM IST
    "Patients with NASH have been enrolled in these trials across clinical sites in India and Mexico," Cadila Healthcare, the listed entity of the group,...
    Abbott wins USFDA approval for blood plasma screening system Alinity s

    Abbott wins USFDA approval for blood plasma screening system Alinity s

    Medical Dialogues Bureau18 July 2019 9:15 AM IST
    Abbott's Alinity s is designed to screen blood and plasma more efficiently within a smaller space versus commercially available competitive...
    Federal data shows opioid shipments ballooned by over 50pc as crisis grew

    Federal data shows opioid shipments ballooned by over 50pc as crisis grew

    Medical Dialogues Bureau18 July 2019 9:00 AM IST
    While OxyContin is the best-known prescription opioid, the Post analysis shows that Purdue accounted for just 3% of pills sold during that time. Three...
    USFDA finds adulteration, violations of CGMP regulations at Strides Pharma Puducherry plant

    USFDA finds adulteration, violations of CGMP regulations at Strides Pharma Puducherry plant

    Farhat Nasim17 July 2019 1:59 PM IST
    The FDA's warning letter dated July 1, comes months after several Indian drugmakers including Sun Pharmaceutical Ltd and Dr Reddy's Laboratories Ltd...
    Despite legal hassles, JnJ beats profit estimates on pharma strength

    Despite legal hassles, JnJ beats profit estimates on pharma strength

    Medical Dialogues Bureau17 July 2019 12:10 PM IST
    Johnson and Johnson's (JnJ) pharmaceuticals unit has cushioned the impact of slow growth in its medical device and consumer health units, largely due...
    Abbott to increase production of lower-cost glucose monitors as diabetes soars

    Abbott to increase production of lower-cost glucose monitors as diabetes soars

    Medical Dialogues Bureau17 July 2019 9:30 AM IST
    CHICAGO: Abbott Laboratories plans to ramp up manufacturing capacity for its lower-cost continuous glucose monitor, the FreeStyle Libre, by three to...
    Novartis sickle cell drug crizanlizumab secures speedy USFDA review

    Novartis sickle cell drug crizanlizumab secures speedy USFDA review

    Medical Dialogues Bureau17 July 2019 9:26 AM IST
    Novartis submitted the application for crizanlizumab for the prevention of vaso-occlusive crises (VOCs) in patients with sickle cell disease (SCD) and...
    Takeda Pharma launches Rare Disease Therapies in India

    Takeda Pharma launches Rare Disease Therapies in India

    Medical Dialogues Bureau17 July 2019 9:25 AM IST
    Under lysosomal storage disorders, India has been recording the prevalence of Hunter syndrome, Gaucher disease and Fabry disease, Takeda said in a...
    PrevNext

    Popular Stories

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    Mediclaim cannot be denied on presumption of pre-existing disease: NCDRC

    Mediclaim cannot be denied on presumption of pre-existing disease: NCDRC

    Coronavirus: Restrictions imposed on the export of medical equipment to China

    Coronavirus: Restrictions imposed on the export of medical equipment to China

    OncoStem Diagnostics named

    OncoStem Diagnostics named 'Best Innovation- Cancer Risk Assessment' by NASSCOM Life sciences and...

    Protect Your Loved Ones with a Term Plan that’s Smart

    Protect Your Loved Ones with a Term Plan that’s Smart

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    FDA warns about potential cybersecurity vulnerabilities for certain GE Healthcare Clinical Information Central Stations and Telemetry Servers

    FDA warns about potential cybersecurity vulnerabilities for certain GE Healthcare Clinical...

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok